Xuxin Ren

665 total citations
8 papers, 390 citations indexed

About

Xuxin Ren is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Xuxin Ren has authored 8 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Oncology. Recurrent topics in Xuxin Ren's work include RNA modifications and cancer (5 papers), Cancer-related gene regulation (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Xuxin Ren is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related gene regulation (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Xuxin Ren collaborates with scholars based in China, Hong Kong and United States. Xuxin Ren's co-authors include Sui Peng, Shuibin Lin, Zhihang Chen, Ming Kuang, Zihao Dai, Hai‐Ning Liu, Shenghua Zhu, Shuling Chen, Wanjie Zhu and Junbin Liao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Cell Metabolism.

In The Last Decade

Xuxin Ren

8 papers receiving 387 citations

Peers

Xuxin Ren

MB

CR

ONCOL

IMMUN

PRM

Zeli Yin China

Xiaoxue Ren China

Zheying Mao China

Sun‐Zhe Xie China

Yong Du China

Xinrui Mao China

Shaowen Jin China

Guangshun Sun China

Tiening Zhang China

Zeli Yin China

Xuxin Ren

217 ×0.8

MB

199 ×1.3

CR

100 ×1.0

ONCOL

84 ×1.0

IMMUN

62 ×1.6

PRM

Citations per year, relative to Xuxin Ren Xuxin Ren (= 1×) peers Zeli Yin

Countries citing papers authored by Xuxin Ren

Since Specialization

Citations

This map shows the geographic impact of Xuxin Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuxin Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuxin Ren more than expected).

Fields of papers citing papers by Xuxin Ren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuxin Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuxin Ren. The network helps show where Xuxin Ren may publish in the future.

Co-authorship network of co-authors of Xuxin Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Xuxin Ren. A scholar is included among the top collaborators of Xuxin Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuxin Ren. Xuxin Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Zhang, Ying, Weixin Liu, Chi Chun Wong, et al.. (2025). Catenibacterium mitsuokai promotes hepatocellular carcinogenesis by binding to hepatocytes and generating quinolinic acid. Cell Metabolism. 37(10). 1998–2013.e7. 2 indexed citations

2.

Chen, Zhihang, Xiaoxue Ren, Qian Zhou, et al.. (2023). Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer. Cancer Research. 83(21). 3544–3561. 33 indexed citations

3.

Wang, Yuanqi, Xiao Xiang, Huadong Chen, et al.. (2023). Intratumoral erythroblastic islands restrain anti-tumor immunity in hepatoblastoma. Cell Reports Medicine. 4(5). 101044–101044. 13 indexed citations

4.

Chen, Mengke, Y. Q. Fang, Ning Zhang, et al.. (2023). The activation of mTOR signalling modulates DNA methylation by enhancing DNMT1 translation in hepatocellular carcinoma. Journal of Translational Medicine. 21(1). 276–276. 14 indexed citations

5.

Dai, Zihao, Wanjie Zhu, Xinyue Zhang, et al.. (2023). METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression. Molecular Therapy. 31(11). 3225–3242. 30 indexed citations

6.

Liu, Hai‐Ning, Xuezhen Zeng, Xuxin Ren, et al.. (2022). Targeting tumour-intrinsic N ⁷ -methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy. Gut. 72(8). 1555–1567. 53 indexed citations

7.

Zeng, Xuezhen, Shumin Li, Haining Liu, et al.. (2022). Eliminating METTL1‐mediated accumulation of PMN‐MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation. Hepatology. 77(4). 1122–1138. 111 indexed citations

8.

Chen, Zhihang, Wanjie Zhu, Shenghua Zhu, et al.. (2021). METTL1 promotes hepatocarcinogenesis via m⁷G tRNA modification‐dependent translation control. SHILAP Revista de lepidopterología. 11(12). e661–e661. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact